 |
|
rituximab
A recombinant chimeric murine/human antibody directed against the CD20 antigen, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes. Following binding, rituximab triggers a host cytotoxic immune response against CD20-positive cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | C2B8 Monoclonal Antibody
IDEC-C2B8 monoclonal antibody | | | | US brand name: | | Rituxan | | | | Foreign brand name: | | Mabthera | | | | Abbreviation: | | MOAB IDEC-C2B8 | | | | Code names: | | IDEC-102
IDEC-C2B8 | | |
|
|
